PAHO Does Not Recommend Taking Products that Contain Chlorine Dioxide, Sodium Chlorite, Sodium Hypochlorite, or Derivatives, 16 July 2020
Fecha
2020Número de documento
PAHO/IMS/PHE/COVID-19/20-0040
Metadatos
Mostrar el registro completo del ítemOtros idiomas
Resumen
PAHO does not recommend oral or parenteral use of chlorine dioxide or sodium chlorite-based products for patients with suspected or diagnosed COVID-19 or for anyone else. There is no evidence of their effectiveness and the ingestion or inhalation of such products could cause serious adverse effects. The information included in this note reflects the available evidence at the date of publication.
Tema
Colecciones
Esta leyenda debe conservarse, junto con la URL original del artículo.Attribution-NonCommercial-ShareAlike 3.0 IGO
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
(2021)[RESUMEN]. Objetivo. Identificar el perfil nutricional de productos alimentarios eximidos de presentar uno o más sellos de advertencia nutricional en el frente del envase durante la primera etapa de vigencia de la Ley 30021 ...
-
(PAHOUnited StatesWashington, D.C., 2025-01-09)High sodium intakes have been recognized as an issue for many Caribbean countries. Given that noncommunicable diseases and their associated mortalities and morbidities are highly prevalent in Caribbean Community Member ...
-
(PAHOUnited StatesWashington, D.C., 2021)The aim of this study was to map existing country policies and initiatives addressing population dietary sodium reduction in the Region of the Americas; to identify policy gaps following what is outlined in the World Health ...
